Skip to Content

Globus Medical Inc Class A GMED

Morningstar Rating
$66.20 +0.06 (0.09%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GMED is trading at a 384% premium.
Price
$66.10
Fair Value
$51.22
Uncertainty
High
1-Star Price
$94.84
5-Star Price
$59.22
Economic Moat
Sxh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GMED is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$66.14
Day Range
$66.0667.50
52-Week Range
$43.3967.89
Bid/Ask
$63.00 / $68.79
Market Cap
$8.94 Bil
Volume/Avg
806,455 / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
28.07
Price/Sales
4.22
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
2.52%

Company Profile

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
5,000

Comparables

Valuation

Metric
GMED
OFIX
ATEC
Price/Earnings (Normalized)
28.07578.37
Price/Book Value
2.240.8638.38
Price/Sales
4.220.642.61
Price/Cash Flow
21.0219.05
Price/Earnings
GMED
OFIX
ATEC

Financial Strength

Metric
GMED
OFIX
ATEC
Quick Ratio
1.231.011.37
Current Ratio
2.332.652.39
Interest Coverage
−9.38−9.60
Quick Ratio
GMED
OFIX
ATEC

Profitability

Metric
GMED
OFIX
ATEC
Return on Assets (Normalized)
7.87%−13.57%−9.36%
Return on Equity (Normalized)
9.71%−19.53%
Return on Invested Capital (Normalized)
8.60%−16.16%−9.08%
Return on Assets
GMED
OFIX
ATEC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
FqjwkhpnVhhmq$181.6 Bil
Stryker Corp
SYK
TpnfxknxrNcdx$132.0 Bil
Boston Scientific Corp
BSX
SslnwcwxJhzjmll$113.4 Bil
Medtronic PLC
MDT
MsqsnkdfdCgryy$107.5 Bil
Edwards Lifesciences Corp
EW
DsddxjmvZmxczt$51.9 Bil
DexCom Inc
DXCM
DtyjzmgllyYhkhf$46.2 Bil
Koninklijke Philips NV ADR
PHG
HmkbmllGfykvf$24.7 Bil
Zimmer Biomet Holdings Inc
ZBH
NhvrsxxtXzryv$22.5 Bil
Steris PLC
STE
CrpzwhfhHdlzlv$22.3 Bil
Align Technology Inc
ALGN
NqcmwtvBnstzd$20.0 Bil

Sponsor Center